Product code QXQ— General Hospital

Paptizer 360

Classification name: Respiratory Accessory Microbial Reduction Device.
Device class: Class 2
Regulation: 21 CFR 880.6993
Advisory panel: General Hospital
Total cleared: 3
First cleared: 2024-08-12
Most recent: 2026-04-29

FDA classification definition

“A respiratory accessory microbial reduction device is a home-use device intended to be used as an adjunct for microbial reduction of compatible respiratory accessories,such as hoses and masks,after cleaning. This device is not intended to replace the original accessory manufacturers cleaning instructions.”
— U.S. Food and Drug Administration, device classification record for product code QXQ under 21 CFR 880.6993, via openFDA

Market context for product code QXQ

FDA has cleared 3 devices under product code QXQ between 2024 and 2026, filed by 2 applicant companies. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.

Clearances per year

20261 clearance
20251 clearance
20241 clearance

Top applicants under product code QXQ

Soclean, Inc.2 clearances
LiViliti Health Products Corporation1 clearance

Recent clearances under product code QXQ

K252471 — Paptizer 360LiViliti Health Products Corporation·2026-04-29
K243815 — SoClean 3+Soclean, Inc.·2025-10-10
DEN210037 — SoClean 3+ Bacterial Reduction DeviceSoclean, Inc.·2024-08-12

Data sourced from openFDA. This site is unofficial and independent of the FDA.